Monday, 31 August 2020

Bristol Myers Squibb Provides Update on Phase 3 IDHENTIFY Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia



source https://www.pharmatutor.org/pharma-news/2020/bristol-myers-squibb-provides-update-on-phase-3-idhentify-trial-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Career for Pharmacy and Biotech at National Agri-Food and Biomanufacturing Institute

Positions: Junior Research Fellow (JRF) (One) Master’s Degree from a recognized University/Institute in M.Sc. Chemistry - Organic / Physical...